Anlon Healthcare’s IPO is set to open for subscription from August 26 to 29, 2025. The Rajkot-based firm aims to issue 1.33 crore fresh shares priced between ₹86 and ₹91 each. The allocation for the IPO includes 75% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 10% for retail investors, with a minimum retail investment of approximately ₹14,924. Currently, there is no grey market activity reported. Established in 2013, Anlon Healthcare specializes in producing APIs and nutraceuticals. The company’s revenue for FY25 grew by 80% to ₹120.46 crore, and its profit doubled to ₹20.52 crore. Proceeds from the IPO will be used for capital expenditures, loan repayments, and working capital.
The final allotment is scheduled for September 1, with the listing taking place on September 3, 2025.